Valvular & structural heart diseaseCohort study
In-Hospital Outcomes After Tricuspid Valve Surgery in the United States
- national cohort
- Nationwide Readmissions Database 2016 to 2022
- multivariable regression
- risk-adjusted
Authors' conclusion
HVH status was associated with lower odds of in-hospital mortality and reduced risk of 30-day nonelective readmission, but greater hospitalization costs. Increased outreach and resource availability at low-volume centers may help alleviate this disparity and enhance the overall value of care in tricuspid valve surgery.
Study context
- Population
- Adults undergoing isolated or concomitant tricuspid valve replacement or repairestimated patients, 21,723 (61.0%) treated at HVH
- Participants
- 35,567 adults
- Exposure
- Treatment at HVH vs low-volume hospital
- HVHn = 21,723
Main finding
As reported in the abstract
Isolated operation
HVH
21.0
%
low-volume hospital
20.2%
P = 0.01
Observational data: associations, not effects.
Further findings
| Outcome | adjusted OR (95% CI) | |
|---|---|---|
| In-hospital mortality · lower odds with HVH · risk-adjusted | 0.56 (0.47–0.68) | |
| 0.512Adjusted odds ratio (log scale) |
| Outcome | difference |
|---|---|
| Hospitalization costs · increased costs with HVH | $6,070 |
Nonhome discharge and 30-day nonelective readmission
- Lower odds of nonhome discharge and 30-day nonelective readmission with HVH status
Baseline characteristics
- HVH patients were older, less commonly females, and more commonly of the highest income quartile
Safety
| Outcome | adjusted OR (95% CI) | |
|---|---|---|
| Cardiac complications · lower odds with HVH · risk-adjusted | 0.83 (0.73–0.94) | |
| 0.512Adjusted odds ratio (log scale) |
Original publication
In-Hospital Outcomes After Tricuspid Valve Surgery in the United States. JACC Adv. Published 12 February 2026. doi:10.1016/j.jacadv.2026.102594
Summarised from the published abstract; every number is checked against it